Cancer risk associated with insulin glargine among adult type 2 diabetes patients--a nationwide cohort study (Q33954827)

30 July 2017

title

Cancer risk associated with insulin glargine among adult type 2 diabetes patients--a nationwide cohort study (English)

1 reference

30 July 2017

1 reference

1 reference

1 reference

Chia-Hsuin Chang

1

1 reference

30 July 2017

Sengwee Toh

2

1 reference

30 July 2017

Jou-Wei Lin

3

1 reference

30 July 2017

Shu-Ting Chen

4

1 reference

30 July 2017

Chuei-Wen Kuo

5

1 reference

30 July 2017

Lee-Ming Chuang

6

1 reference

30 July 2017

Mei-Shu Lai

7

1 reference

30 July 2017

language of work or name

English

0 references

publication date

27 June 2011

1 reference

30 July 2017

1 reference

30 July 2017

volume

6

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

e21368

1 reference

Creative Commons Attribution 4.0 International

30 July 2017

copyright license

start time

27 June 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

A basic study design for expedited safety signal evaluation based on electronic healthcare data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3124499

Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3124499

Insulin analogues and cancer risk: cause for concern or cause célèbre?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3124499

Diabetes mellitus type 2 - an independent risk factor for cancer?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3124499

Combined randomised controlled trial experience of malignancies in studies using insulin glargine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3124499

Insulin glargine and malignancy: an unwarranted alarm

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3124499

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3124499

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3124499

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3124499

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3124499

Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3124499

Proliferation of colo-357 pancreatic carcinoma cells and survival of patients with pancreatic carcinoma are not altered by insulin glargine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3124499

Marginal structural models and causal inference in epidemiology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3124499

Does diabetes therapy influence the risk of cancer?

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0021368

Diabetes therapy and cancer risk: causal effects and other plausible explanations

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0021368

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0021368

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21738645

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Diabetes and Cancer: A Consensus Report

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21738645

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PONE.0021368

1 reference

30 July 2017

0 references

1 reference

30 July 2017

1 reference